Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mehta-Shah, Neha
1009  Ergebnisse:
Personensuche X
?
1

TCL-394 Valemetostat for Patients With R/R Peripheral T-Cel..:

Horwitz, Steven ; Izutsu, Koji ; Mehta-Shah, Neha...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S524-S525 , 2024
Link: https://doi.org/10.1016/..
 
?
2

SOHO State-of-the-Art Updates and Next Questions: Treatment..:

Burton, Jackson S. ; Foley, Nicole C. ; Mehta-Shah, Neha
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  2 - p. 65-76 , 2024
Link: https://doi.org/10.1016/..
 
?
3

ABCL-607 Trial in Progress: Phase 1 Study With Dose Expansi..:

Nizamuddin, Imran ; Kahl, Brad ; Bartlett, Nancy..
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S485-S486 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Blinatumomab consolidation post–autologous stem cell transp..:

Ghobadi, Armin ; Foley, Nicole C. ; Cohen, Jared...
Blood Advances.  8 (2024)  3 - p. 513-522 , 2024
Link: https://doi.org/10.1182/..
 
?
5

Nivolumab plus brentuximab vedotin for relapsed/refractory ..:

Zinzani, Pier Luigi ; Salles, Gilles ; Moskowitz, Alison J....
Blood Advances.  8 (2024)  10 - p. 2400-2404 , 2024
Link: https://doi.org/10.1182/..
 
?
6

Characteristics and Outcomes in Patients With Marginal Zone..:

Nizamuddin, Imran ; Watkins, Marcus ; Bartlett, Nancy L...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S224 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Trial in Progress: Phase 1 Study With Dose Expansion of Aca..:

Nizamuddin, Imran ; Kahl, Brad ; Bartlett, Nancy..
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S219 , 2024
Link: https://doi.org/10.1016/..
 
?
8

ASTCT and USCLC Clinical Practice Recommendations for Allog..:

Goyal, Amrita ; O'Leary, Daniel ; Dabaja, Bouthaina...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
9

Valemetostat for Patients With R/R Peripheral T-Cell Lympho..:

Horwitz, Steven ; Izutsu, Koji ; Mehta-Shah, Neha...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S155 , 2024
Link: https://doi.org/10.1016/..
 
?
10

The CNS relapse in T-cell lymphoma index predicts CNS relap..:

Bhansali, Rahul S. ; Ellin, Fredrik ; Relander, Thomas...
Blood Advances.  8 (2024)  13 - p. 3507-3518 , 2024
Link: https://doi.org/10.1182/..
 
?
11

Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, ..:

Song, Yuqin ; Malpica, Luis ; Cai, Qingqing...
The Lancet Oncology.  25 (2024)  1 - p. 117-125 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Duvelisib plus romidepsin in relapsed/refractory T cell lym..:

Horwitz, Steven M. ; Nirmal, Ajit J. ; Rahman, Jahan...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
13

Neoantigen landscape supports feasibility of personalized c..:

Ramirez, Cody A. ; Becker-Hapak, Michelle ; Singhal, Kartik...
Blood Advances.  8 (2024)  15 - p. 4035-4049 , 2024
Link: https://doi.org/10.1182/..
 
?
14

Phase I Study of Duvelisib Study for Cytokine Release Syndr..:

Slade, Michael ; Rettig, Michael P. ; Crees, Zachary D...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S118-S119 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Valemetostat for Patients With R/R Peripheral T-Cell Lympho..:

Horwitz, Steven ; Izutsu, Koji ; Mehta-Shah, Neha...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  - p. S229 , 2024
Link: https://doi.org/10.1016/..
 
1-15